Bivalacqua TJ - Search Results

1

Predictive biomarkers for drug response in bladder cancer.

Yoshida T, Kates M, Fujita K, Bivalacqua TJ, McConkey DJ. Yoshida T, et al. Among authors: bivalacqua tj. Int J Urol. 2019 Nov;26(11):1044-1053. doi: 10.1111/iju.14082. Epub 2019 Aug 1. Int J Urol. 2019. PMID: 31370109 Review.

2

Urethral carcinosarcoma from bladder carcinosarcomatous lesions: analysis of clinicopathological features.

Bivalacqua TJ, Bagga HS, Patil K, Magheli A, Taube JM, Guzzo TJ, Gonzalgo ML. Bivalacqua TJ, et al. Can J Urol. 2009 Feb;16(1):4512-5. Can J Urol. 2009. PMID: 19222894

3

Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer.

Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, Attenello FJ, Schoenberg MP, Gonzalgo ML. Guzzo TJ, et al. Among authors: bivalacqua tj. Urology. 2009 Dec;74(6):1276-80. doi: 10.1016/j.urology.2009.05.092. Epub 2009 Sep 16. Urology. 2009. PMID: 19758684

4

Metabolomics and bladder cancer.

Hyndman ME, Mullins JK, Bivalacqua TJ. Hyndman ME, et al. Among authors: bivalacqua tj. Urol Oncol. 2011 Sep-Oct;29(5):558-61. doi: 10.1016/j.urolonc.2011.05.014. Urol Oncol. 2011. PMID: 21930087

5

In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States.

Kates M, Gorin MA, Deibert CM, Pierorazio PM, Schoenberg MP, McKiernan JM, Bivalacqua TJ. Kates M, et al. Among authors: bivalacqua tj. Urol Oncol. 2014 Jan;32(1):53.e9-14. doi: 10.1016/j.urolonc.2013.08.024. Epub 2013 Nov 13. Urol Oncol. 2014. PMID: 24239467

6

Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.

Gorin MA, Kates M, Mullins JK, Pierorazio PM, Matlaga BR, Schoenberg MP, Bivalacqua TJ. Gorin MA, et al. Among authors: bivalacqua tj. Can J Urol. 2014 Feb;21(1):7102-7. Can J Urol. 2014. PMID: 24529009

7

The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.

Reese AC, Ball MW, Gandhi N, Gorin MA, Netto GJ, Bivalacqua TJ, Schoenberg MP. Reese AC, et al. Among authors: bivalacqua tj. Urology. 2014 Aug;84(2):358-63. doi: 10.1016/j.urology.2014.03.040. Urology. 2014. PMID: 25065987 Free PMC article.

8

Reply: To PMID 25065987.

Reese AC, Bivalacqua TJ, Schoenberg MP. Reese AC, et al. Among authors: bivalacqua tj. Urology. 2014 Aug;84(2):364. doi: 10.1016/j.urology.2014.03.045. Urology. 2014. PMID: 25065989 No abstract available.

9

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Zargar H, et al. Among authors: bivalacqua tj. Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23. Eur Urol. 2015. PMID: 25257030 Free PMC article.

10

Tissue-engineered urinary conduits.

Kates M, Singh A, Matsui H, Steinberg GD, Smith ND, Schoenberg MP, Bivalacqua TJ. Kates M, et al. Among authors: bivalacqua tj. Curr Urol Rep. 2015 Mar;16(3):8. doi: 10.1007/s11934-015-0480-3. Curr Urol Rep. 2015. PMID: 25677229 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page